| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 560.89B | 550.18B | 523.72B | 516.95B | 486.58B | 432.57B |
| Gross Profit | 97.36B | 95.26B | 88.61B | 76.93B | 91.35B | 90.07B |
| EBITDA | 43.47B | 43.12B | 38.83B | 32.45B | 47.01B | 28.46B |
| Net Income | 12.96B | 12.38B | 9.04B | 7.20B | 16.76B | 3.37B |
Balance Sheet | ||||||
| Total Assets | 529.43B | 544.31B | 544.10B | 526.20B | 532.60B | 506.95B |
| Cash, Cash Equivalents and Short-Term Investments | 30.92B | 34.71B | 35.21B | 31.30B | 45.19B | 61.23B |
| Total Debt | 165.29B | 173.74B | 161.32B | 168.74B | 160.93B | 150.59B |
| Total Liabilities | 280.98B | 293.83B | 305.10B | 305.44B | 311.69B | 299.85B |
| Stockholders Equity | 231.34B | 233.13B | 222.16B | 205.47B | 203.09B | 190.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.98B | 16.00B | -15.82B | -17.16B | 17.70B |
| Operating Cash Flow | 0.00 | 12.06B | 38.04B | 695.00M | 1.49B | 41.94B |
| Investing Cash Flow | 0.00 | -19.11B | -23.93B | -15.12B | -18.02B | -25.67B |
| Financing Cash Flow | 0.00 | 6.24B | -11.05B | 85.00M | -626.00M | 8.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥182.56B | 17.88 | 5.78% | 1.49% | 0.82% | -1.72% | |
72 Outperform | ¥169.11B | 6.54 | 6.34% | 3.02% | 6.23% | 11.86% | |
71 Outperform | ¥101.56B | 19.55 | ― | 1.38% | -3.56% | -30.17% | |
68 Neutral | ¥85.23B | 7.97 | ― | 2.98% | 8.89% | 102.20% | |
64 Neutral | ¥416.90B | 5.47 | 6.36% | 1.91% | 11.31% | -25.76% | |
59 Neutral | ¥53.38B | 13.94 | 0.07% | 4.88% | 16.98% | -96.24% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |